255 filings
Page 2 of 13
8-K
wz0xvh17dw7me xml5
14 Mar 23
Departure of Directors or Certain Officers
4:03pm
8-K
0nxrpg5zg2
8 Mar 23
Other Events
4:25pm
8-K
crtsy0cyne 9k6x1
1 Mar 23
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
12:00am
8-K
ijo2tif
8 Nov 22
Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:07pm
8-K
9a3djb
7 Nov 22
Other Events
4:06pm
8-K
ceubzbny x1d
9 Aug 22
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
12:00am
424B5
htz1zidergh
23 Jun 22
Prospectus supplement for primary offering
4:09pm
8-K
tvvaiowkc
23 Jun 22
Other Events
4:04pm
424B5
bxsh7v3hxis
22 Jun 22
Prospectus supplement for primary offering
4:05pm
8-K
8clwv89aeh7xg t1
21 Jun 22
Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA
7:03am
S-8
15cdt
2 Jun 22
Registration of securities for employees
4:18pm
8-K
re78e56
2 Jun 22
Departure of Directors or Certain Officers
4:03pm
8-K
rfmj5w5 p2
10 May 22
Xenon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:16pm
8-K
l641br999qn
22 Mar 22
Unregistered Sales of Equity Securities
4:04pm